| 摘要 |
FIELD: medicine.SUBSTANCE: there are determined: peak expiratory flow rate (PEFR), l/min, and reference peak expiratory flow rate (PEFRR), l/min; child's age (A), completed years, height (H), cm; body weight (W), kg accurate to 0.1 kg; coefficients are established as followed: sexual identity (S) - 1 for males, 0 - for females; severity of the clinical course (S) - 1 mild BA, 2 moderate BA, 3 severe BA; baseline therapy (BT) prescribed - 1 if the child has been receiving the therapy for one pre-examination year, 0 has not; a degree of severity of BA episode (SE) - 1 mild degree of severity of the episode, 2 - moderate degree of severity of the episode, and 3 severe episode. A peak expiratory flow rate coefficient (PEFRC) is calculated as the relation (PEFR/PEFRR)×100%. Cardiointervalography is performed, and a vagosympathetic balance coefficient is calculated (LF/HF). An efficacy coefficient (K) of the preparation Berodual for rapid relief of the bronchial asthma episode is described by formula; if K>12, the rapid relief of the bronchial asthma episode the preparation Berodual is considered to be effective.EFFECT: method enables providing more reliable assessment of using the preparation Berodual for rapid relief of the bronchial asthma episode in a child that is ensured by collective assessment of clinical and functional signs of the patient's health.3 ex |
